Product Overview

Tranexamic Acid, also known as Tranexamic Acid, TXA / transamin, complies with multiple pharmacopoeia standards including CP2010, USP42, BP2019, JP17, and EP9.0, with production and management strictly following GMP standards. It is a potent whitening ingredient that acts on the skin through a multi-dimensional approach: rapidly inhibiting tyrosinase and melanocyte activity while preventing melanin aggregation, effectively disrupting the pathway of increased melanin production caused by UV exposure, helping to prevent and improve pigmentation issues. With its excellent anti-inflammatory effects, it effectively soothes the skin, maintains skin function, and reduces factors that promote melanin production, widely used in pharmaceuticals, cosmetics, oral care products, and more.

INCI Name CAS No. Molecular Formula Molecular Weight
Tranexamic Acid 1197-18-8 C8H15NO2 157.21
Appearance Odor Solubility pH value (1% aqueous solution)
White Crystalline Powder Odorless or Nearly Odorless Soluble in Water 7.0 – 8.0

Technical Specifications

Item Specification Test Method
Content (on dry basis) ≥ 99.0% HPLC
Loss on Drying ≤ 0.5% GB/T 6284
Residue on Ignition ≤ 0.1% GB/T 9741
Heavy metals (as Pb) ≤ 10 ppm ICP-MS
Arsenic (As) ≤ 2 ppm ICP-MS
Total Plate Count ≤ 100 CFU/g GB 4789.2
Total yeast and mold count ≤ 10 CFU/g GB 4789.15
Pathogenic Bacteria Not Detected GB 4789.4/GB 4789.10
Compliant with Pharmacopoeia Standards CP2010 / USP42 / BP2019 / JP17 / EP9.0 Multi-Pharmacopoeia Compliance

* The above data are typical values and are not specifications.

Product Advantages

Rapid Melanin Inhibition
Rapidly reduces tyrosinase and melanocyte activity, preventing melanin accumulation
Anti-inflammatory Effect
Effectively alleviates skin stress caused by inflammation, reducing the risk of melanin accumulation induced by stress
Prevents Secondary Oxidation
Inhibits secondary oxidation of melanin (Meyer reaction), preventing further pigmentation
Multi-Pharmacopoeia Compliance
Complies with multiple international pharmacopoeia standards including CP2010, USP42, BP2019, JP17, and EP9.0
Medical and oral care applications
Can be used for hemostasis, treating melasma, and also suitable for hemostatic and antibacterial applications in toothpaste

Application Guide

Recommended dosage: 0.5% – 3.0%, optimal dosage 1.0% – 2.0%, easily soluble in water, suggested to be added late in the formulation, optimal pH 5.5 – 7.5.

Skin Care Products
Serums, creams, lotions, masks, etc.
Color Cosmetics
Liquid foundation, pressed powder, cushion compact, etc.
Personal Care
Facial cleanser, body lotion, etc.
Pharmaceutical Field
Hemostatic agent, tonsillitis, pulmonary tuberculosis hemoptysis, acne, melasma treatment
Oral Care
Added to toothpaste for hemostatic, antibacterial, and anti-inflammatory effects

Recommended Formulation

Tranexamic Acid performs excellently in whitening, spot removal, and barrier repair formulations, with the following recommended formulation examples:

Packaging & Storage

Packaging Specifications
25 kg / drum
Storage Conditions
Keep sealed, store in a cool, dry place
Shelf Life
24 months (unopened)